11 Dez 2017 Jahr - FDA hosted a public workshop addressing abuse,
misuse, or inappropriate access of prescription
opioid drug products; ways in which FDA
could encourage the development and
assessment of packaging, storage, and disposal
options for opioids that have the potential to
enhance opioid safety.
Zugefügt zum Band der Zeit:
Opioids and the FDA
Datum:
